Kun Yu

机构：Fujian Medical University, Union Hospital · ORCID：0009-0004-5623-6431

发表论文 45 篇 · 总被引 4097 次 · h-index 17

代表论文

• Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer (2020 · Nature Medicine · 被引 546)
• miR-224, miR-147b and miR-31 associated with lymph node metastasis and prognosis for lung adenocarcinoma by regulating PRPF4B, WDR82 or NR3C2 (2020 · PeerJ · 被引 25)
• An improved binary particle swarm optimization algorithm for clinical cancer biomarker identification in microarray data (2023 · Computer Methods and Programs in Biomedicine · 被引 21)
• Multimodal treatment based on thyroidectomy improves survival in patients with metastatic anaplastic thyroid carcinoma: a SEER analysis from 1998 to 2015 (2020 · Gland Surgery · 被引 20)
• Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer (2020 · Frontiers in Oncology · 被引 17)
• Impact of prior cancer history on survival of patients with gastric cancer (2021 · European Journal of Surgical Oncology · 被引 16)